论文部分内容阅读
胰腺癌约占全身恶性肿瘤的2%,近年来国内外报道其发病率明显增长[1]。尽管手术方式的改进及放疗、化疗等综合措施的引进降低了胰腺癌患者的并发症和死亡率,但5年生存率仍不到2%[2]。因此,深入进行胰腺癌的基础与临床研究,改善胰腺癌患者的预后,仍是当前胰腺肿瘤领域研究的难点。随着人类基因组计划的完成及HapMap图谱和基因结构图的公
Pancreatic cancer accounts for about 2% of systemic malignancies. In recent years, the incidence of pancreatic cancer has been significantly increased at home and abroad [1]. Although the improvement of surgical methods and the introduction of comprehensive measures such as radiotherapy and chemotherapy reduce the complication and mortality of patients with pancreatic cancer, the 5-year survival rate is still less than 2% [2]. Therefore, in-depth study of basic and clinical pancreatic cancer and improve the prognosis of patients with pancreatic cancer is still the current difficulties in the field of pancreatic cancer research. With the completion of the Human Genome Project and the HapMap map and gene map of the public